H.C. Wainwright
About H.C. Wainwright
H.C. Wainwright is a boutique investment bank based in New York, offering financial services including investment banking, advisory, and research. The firm provides capital markets services, equity research coverage, and corporate access to clients, with a focus on clients in healthcare and life sciences. It operates through divisions such as investment banking, advisory, research, sales and trading, and events, serving clients domestically with additional activities through its online presence. Headquarters are located at 430 Park Avenue, New York, NY 10022.
Recent News
Here Is Why Ovid Therapeutics (OVID) Is One of the Best Fast Growing Penny Stocks
What Does H.C. Wainwright See in Electrovaya (ELVA) Despite Its Near-Term Revenue Cut?
H.C. Wainwright Reduced Its Price Goal on Summit Therapeutics Inc. (SMMT)
Telix Pharma's TLX101-Px NDA Acceptance Boosts Shares, Eyes Sep 2026 FDA Decision
Barclays Reiterates Overweight on BridgeBio Stock, Cites Attruby Strength
Beam Therapeutics (BEAM): Among the Stocks That Could 10x Over the Next 5 Years
H.C. Wainwright Is Bullish on Relay Therapeutics, Inc. (RLAY)
Fairmount Funds Sells Cogent Biosciences (COGT) Shares for $242.6m
Wave To Work Alone on RNA Editor as AATD Picture Becomes Clearer
Sarepta Saga Has 'Gone on Too Long' As Competitors Catch Up
Biogen Price Target Raised to $200 From $190 at Morgan Stanley
Psychedelics Space at a ‘Tipping Point’ as Compass, Definium Gear Up To File for Approval
Here’s the Impact of Applied Digital Corp (APLD) Differentiation in the Data Center Market
What’s Driving Erasca (ERAS)’s Nearly 355% YTD Return
Ligand Pharmaceuticals Acquires XOMA Royalty in a $739 Million Deal
Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
8 Most Oversold Penny Stocks to Buy Right Now
Recent Deals
No recent deals for this company.